Venereal infection of mares by equine arteritis virus and use of killed vaccine against the infection.
Venereal infection with equine arteritis virus (EAV) was established in each of seven mares by inoculation via the cervix with 20 ml of viral suspension (> or = 8 x 10(6) plaque-forming units; PFU), following treatment with prostaglandin and oestradiol. A dose of < or = 8 x 10(5) PFU produced infection in only five of eight mares. Serum neutralizing antibody developed in mares manifesting clinical signs of equine viral arteritis (EVA), and a weak antibody was detectable in one apparently healthy mare inoculated with 8 x 10(5) PFU. Virus isolation was demonstrated not only in the buffy coat but also in nasal swabs of infected mares. EAV was isolated frequently from the body tissues of the mares (killed 10 to 34 days post-inoculation) up to day 12, but rarely from the reproductive tissues later than day 12. The virus persisted longest in the splenic and deep inguinal lymph nodes, followed by the spleen and internal iliac lymph nodes. Four mares immunized with a killed vaccine for EVA showed no clinical disease after venereal challenge with EAV; the virus was recovered from the buffy coat of three mares and from the nasal swab of one of them, but not from the remaining animal.
Fukunaga
Y
Y
Epizootic Research Station, Japan Racing Association, Tochigi.
Wada
R
R
Imagawa
H
H
Kanemaru
T
T
D000818:Animals; D018174:Arterivirus Infections / Q000276:immunology / Q000635:transmission / Q000662:veterinary*; D007240:Equartevirus / Q000276:immunology* / Q000302:isolation & purification; D005260:Female; D006734:Horse Diseases / Q000276:immunology / Q000635:transmission / Q000821:virology*; D006736:Horses; D015229:Sexually Transmitted Diseases, Viral / Q000276:immunology / Q000662:veterinary*; D002577:Uterine Cervical Diseases / Q000276:immunology / Q000662:veterinary; D014611:Vaccination / Q000662:veterinary; D015164:Vaccines, Inactivated / Q000276:immunology*
D015164:Vaccines, Inactivated